Core Viewpoint - DexCom, Inc. (DXCM) is expected to report second-quarter 2025 results on July 30, with revenue estimates at $1.12 billion, reflecting an 11.8% year-over-year growth, and earnings per share (EPS) forecasted at 45 cents, indicating a 4.7% increase from the previous year [1][2][6] Group 1: Financial Performance - In the last reported quarter, DexCom's earnings missed estimates by 3.03%, with an average surprise of 0.47% over the past four quarters [1] - The company has seen its shares increase by 11.1% year-to-date, outperforming the industry decline of 10.2% and the S&P 500 Index's increase of 6.9% [1] - DexCom's full-year 2025 revenue guidance is set at $4.6 billion, representing organic growth of 14%, with expected gross and operating margins of approximately 62% and 21%, respectively [10] Group 2: Growth Drivers - Key growth factors for the second quarter include the expansion of the U.S. prescriber base, strong international performance, and the traction of Stelo, an over-the-counter continuous glucose monitor [3][8] - The company's continuous glucose monitoring (CGM) system is now covered by two of the three largest pharmacy benefit managers (PBMs), likely leading to increased adoption [4] - DexCom reported a record number of new patient starts in the past two quarters, indicating improved commercial execution and strong U.S. demand [7] Group 3: International Market Dynamics - The international segment of DexCom showed resilience, growing 7% year-over-year, driven by coverage expansion for type 2 diabetes patients, particularly in Japan and France [7] - The anticipated ramp-up of the G7 CGM and international growth are expected to aid margins in the upcoming quarter [6][10] Group 4: Product Innovations - Stelo is positioned as a significant growth driver for DexCom, targeting individuals with prediabetes and Type 2 diabetes who are not on insulin [8] - The company is enhancing Stelo's adoption through product iterations, awareness campaigns, and new distribution channels, including its launch on Amazon [9]